TD Cowen lifts target for Schrödinger stock to USD 31.00

Published on 10/15/2026 at 21:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Schrödinger gained 40.10 percent year to date on October 14, 2026. Schrödinger stock costs EUR 22.82 on October 15, 2026, up 2.20 percent on the Nasdaq.

TD Cowen updates its target

On October 13, 2026, TD Cowen lifted its Schrödinger target to USD 31.00 from USD 20.00.
Schrödinger gained 40.10 percent year to date as of October 14, 2026.
Schrödinger stock costs EUR 22.82 at Lang & Schwarz on October 15, 2026 at 9:45 p.m. CEST, up 2.20 percent on Nasdaq.
Schrödinger is estimated to report third-quarter results on November 4, 2026.

SDGR, US80810D1037, Illustration mit AI erstellt.

TD Cowen raised its price target for Schrödinger from USD 20.00 to USD 31.00 on October 13, 2026, according to Markets Insider. The new target stands 21.09 percent above the Nasdaq price of USD 25.60. At Lang & Schwarz, the stock was trading at EUR 22.82 on October 15, 2026 at 9:45 p.m. CEST.

Schrödinger spans two businesses

Schrödinger's platform combines software for molecular discovery with a drug-discovery business. Its investor-relations page says the technology serves life-science and materials-science customers while the company advances proprietary and collaborative drug programs, according to Schrödinger.

The operating picture is important because the latest published quarter, the second quarter of 2026, produced USD 58.89 million in revenue and USD 5.98 million in consolidated net income. Those figures are historical operating context, while the analyst target reflects expectations for the next phase of execution.

Year-to-date gain reaches 40.10 percent

Schrödinger was up 40.10 percent year to date as of October 14, 2026. Its 52-week range was USD 10.95 to USD 33.78, leaving the Nasdaq price of USD 25.60 below the high and above the low. The October 15 Nasdaq quote was last at USD 25.60 at 3:52 p.m. ET, with regular trading open.

Valuation and November 4 date

The market capitalization was USD 1.9 billion on October 15, 2026, and the trailing price-to-earnings ratio was minus 34.59. The next earnings date is estimated for November 4, 2026, after the market closes, with the conference call scheduled for 4:30 p.m. ET, according to MarketBeat.

Comparison with peers

Schrödinger (Nasdaq, USD): plus 2.20 percent, price-to-earnings ratio minus 34.59, market capitalization USD 1.9 billion

Recursion Pharmaceuticals (Nasdaq, USD): plus 12.70 percent, price-to-earnings ratio minus 4.00, market capitalization USD 2.3 billion

AbCellera Biologics (Nasdaq, USD): plus 3.23 percent, price-to-earnings ratio minus 23.65, market capitalization USD 4.1 billion

Trading ends in after-hours

At Lang & Schwarz, Schrödinger stock was trading at EUR 22.82 on October 15, 2026 at 9:45 p.m. CEST. The Nasdaq quote was up 2.20 percent on the day, while the stock remained below its USD 33.78 52-week high.

The further course of trading is shown by the continuously updated real-time quote of Schrödinger stock.